TB screening to improve preventive therapy in pregnant women with HIV
Part of Immune system & allergy, Infections clinical trials.
This trial looks at whether screening pregnant women with HIV for tuberculosis (TB) and offering preventive treatment can improve health for both mother and baby. It may help keep you from getting active TB and protect your health during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (not twins or more).
- You have HIV.
- You are not currently taking or planning to take TB treatment.
- You haven't taken any drug that kills TB germs in the last 2 weeks.
- You haven't been treated for TB or taken TB preventive therapy in the last 2 years.
- You live within 20 km (about 12 miles) of the study site and plan to deliver there.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding HIV prevention services to routine TB household contact checks can help more people stay healthy. If you or someone you live with has TB, you may be able to join.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study tests a community-friendly way to deliver TB prevention medicine (called TPT) to people's homes in Kenya. Researchers want to see if bringing screening and treatment to your house—instead of making you go to a clinic—helps more people start and finish TB prevention, which can reduce TB spread in your community.
This study looks at how well a daily pill called PrEP can prevent HIV in pregnant women and their babies. It aims to make sure these women get the support they need to stay healthy.
This trial tests whether giving TB treatment through community pharmacies can improve health outcomes for people living with both TB and HIV. It aims to make treatment more convenient and support better adherence.
This study tests a daily combination of two medicines, rifapentine and isoniazid, to prevent tuberculosis (TB) in children under 13 years old. It aims to see if this short treatment is safe and works well for kids, including those living with HIV.
Hear when a new Pregnant HIV Positive Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.